• Rani Therapeutics appointed Nicholas Maestas as chief financial officer, effective immediately.
• Maestas previously served as CFO, head of corporate strategy at Tempest Therapeutics, leading multiple financing transactions.
• He succeeds Svai Sanford, who announced in May 2026 he would depart to pursue another professional opportunity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606290800PRIMZONEFULLFEED9753755) on June 29, 2026, and is solely responsible for the information contained therein.